IPSO 2026 Congress Program

Inspiring Innovation, Transforming Care, and Improving Outcomes in Pediatric Stroke

May 27th-29th, 2026

Paris, France

The IPSO 2026 Congress will offer: 

• Both multidisciplinary and international speakers
• Diverse content of interest to multiple disciplines 
• Content will range from clinical review sessions to clinical debates
• Oral Abstract & Poster Sessions 
• Networking with Colleagues & Industry Sponsors 
• IPSO committees, councils, and working groups meetings

Note: This program is subject to change. 

Times in CET. 

Day 1: Wednesday, May 27^th, 2026

• Opening Remarks 
• Keynote: Pierre Lasjaunias Memorial, The History of Congenital Arteriovenous Fistulas
• Clinical Debate Session: Management of Cervical Arteriopathies
  • Management of Cervical Artery Dissection: Adult Neurologist’s Perspective
  • Management of Cervical Artery Dissection: Pediatric Neurologist’s Perspective
  • Rotational Vertebral Arteriopathy: Recognition, Etiologies, and Treatment
    
• Coffee Break
• Clinical Advances Session: New Tools/ Treatments for Identifying Patients at High Risk for Stroke
  • Imaging Cerebral Perfusion and Cerebrovascular Reserve
  • Real-Time Stroke Detection in High-Risk Cardiac Patients
  • New Approaches to Moyamoya Revascularization: Burr holes with Erythropoietin
• Clinical Advances Session: Venous Sinus Thrombosis
  • KidsDOTT Trial and CSVT: Shorter Anticoagulation Treatment? Anticoagulation for Infectionprovoked CSVT
  • Venous Thrombosis Secondary to Infection: From Lemierre Syndrome to Otitic Hydrocephalus
• Lunch and Poster Session
  
• Clinical Advances Session: Perinatal Stroke: From Pathophysiology to Recovery
  • Pathophysiology of Fetal and Perinatal Stroke: Sex Differences and the Role of the Placenta
  • Anatomic and Functional Neuroimaging After Perinatal Stroke
  • Improving Outcomes after Perinatal Stroke: the Results of the Dinosaur Trial (Darbepoetin for Ischemic Neonatal Stroke to Augment Regeneration)
  • Improving Outcomes after Perinatal Stroke: The Results of the I-ACQUIRE trial
  • A Multimodal Approach to Neonatal Stroke Recovery: Clinical Outcomes and Their Evolution Over Childhood
• Coffee Break
• Clinical Review Session: The Role of Infection in Intracranial Vasculopathies
  • Global Perspective: HIV-Related Intracranial Vasculopathies in Africa
  • Global Perspective: Intracranial Vasculitis Due to Tuberculosis Meningitis in India
  • Focal Cerebral Arteriopathy as a Post-infectious Arteriopathy: The Role of VZV, SARS-CoV2, and Other Infections
  • Oral Abstract
• Day 1 Ends
  

Day 2: Thursday, May 28^th, 2026

• Day 2 Welcome
  
• Clinical Review Session: Rare Neurovascular Diseases that You Should Not Miss
  • The Eye/Brain Connection: Bonnet-Dechaume-Blanc or Wyburn-Mason syndrome
  • The Eye/Brain/Gut/Bladder Connection: ACTA2 Deficiency and Other Smooth Muscle Disorders
  • Deficiency of Adenosine Deaminase 2 (DADA2): a Rare but Treatable Monogenic Vasculitis
  • Dural Sinus Malformation: Diagnosis and Management
  • Oral abstract
• Coffee Break
• Clinical Advances Session: Bridging Gaps in Stroke Systems
  • Integrating Children into Adult Stroke System of Care
  • Setting Up Pediatric Systems of Care
  • Global Perspective: Pediatric Stroke Care in South America
  • Global Perspective: Pediatric Stroke Care in Egypt
• Clinical Advances Session: Acute Arterial Ischemic Stroke Management
  • Selecting Patients for Thrombectomy: Imaging for a Pediatric Stroke Code
  • Current Approaches to Thrombolytics: Tenecteplase Versus Alteplase 
• Lunch and Poster Session
• Oral Abstract Session: Late Breaking Research 
• Coffee Break
• Clinical Advances Session: Preventing Hemorrhagic Stroke in Children
  
  • Fetal ICH and COL4A1/ A2
  • Genetics in Vascular Malformations
  • Update on Emerging Medical Therapies for Cavernous Malformations
  • Global Perspective: Management of Pediatric Arteriovenous Malformations in Kazakstan
    
• Business Affairs 
• Day 2 Ends
  

Post Congress: Thursday, May 28^th, 2026

• Congress Dinner Event

Day 3: Friday, May 29^th, 2026,

• Day 3 Welcome
  
• Challenging Case Conference, INR Focused
• Clinical Review Session: Improving Recovery after Pediatric Stroke 
  • Patient Family centered care
  • Goal Oriented Intensive Therapies
  • Use of Innovation/ New Technologies
  • Overview of Interventions Aiming at Improving Cognitive, Behavioral and Emotional Impairments 
    
• Clinical Review Session: IPSO Clinical Guidelines
  • IPSO Hemorrhagic Stroke Guidelines
  • Best Practices in Pediatric Interventional Neuroradiology (INR): Results of a Delphi Consensus Survey 
  • IPSO Guidelines: How to Set Up a New Working Group
• Coffee Break
• INR Session: Debate on Acute Endovascular Management
  • Consortia to Discuss Real-world Outcomes, Device Selection, and System-of-Care Implications
  • Discuss ‘Small child’ Dedicated Devices / Access
• Late Breaking Science Session
  
• Closing Remarks
• IPSO 2026 Congress Ends
  
• Post-Congress Meetings
  • Board of Directors Meeting
  • IPSO Committee/Working Group Meetings (TBD)